Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The RhIL-1ra Phase III Sepsis Syndrome Study Group. - Knaus,WA.; Harrell,Jr.FE.; LaBrecque,JF. (Crit Care Med, 1996)